Compare RCKT & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCKT | SDHY |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 394.0M |
| IPO Year | N/A | N/A |
| Metric | RCKT | SDHY |
|---|---|---|
| Price | $3.23 | $16.10 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.73 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 65.3K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | ★ N/A | $15.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.40 | $15.55 |
| 52 Week High | $5.45 | $17.18 |
| Indicator | RCKT | SDHY |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 54.45 |
| Support Level | $3.32 | $15.87 |
| Resistance Level | $3.52 | $16.25 |
| Average True Range (ATR) | 0.18 | 0.17 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 96.47 | 57.89 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.